Original Brand drug
Epclusa (Sofosbuvir/Velpatasvir) is the world’s first all-oral, pan-genotypic, single-tablet hepatitis C treatment regimen, taken orally once daily, for all 6 genotypes (GT-1, -2, -3, -4, -5,-6) Treatment of hepatitis C patients.
Currently, there are 26 versions of sofosbuvir/velpatasvir tablets available in the Asia-Pacific region.
Generic Drugs
- Indian Natco:Hepcinat (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Natco:Velsof (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Hetero Drugs Ltd:Velasof(Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Hetero Drugs Ltd:Велсоф(Противомикробные/Противовирусные)400mg/100mg tablets
- Indian Cipla Ltd:HEPCVEL(Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Zydus Cadila:SoviHep V(Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Cadila Healthcare Ltd (Zydus):Velakast (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Dr Reddy’s Lab: Resof (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Mylan Pharma: MYHep All (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Abbott: Velpaclear (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Torrent Pharma: Velpacruz S(Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Emcure Pharma:Sofocure v(Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Taj Pharma: Hepcitaj-SV (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Stride Pharma: VIRVEL (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Indian Healthiza Life: Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Bangladesh Beacon Pharma: Sofosvel (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Bangladesh Incepta Pharma-Sofosbuvir/Velpatasvir-Panovir (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Bangladesh Everest Pharma-Sofosbuvir/Velpatasvir-Velpanex (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Bangladesh Drug International limted(DIL): HopeSo-VL (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Pakistan Getz Pharma: Velpaget (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Pakistan Sami Pharma: Ocvir-V (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Pakistan Aspin Pharma: Sofvel (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Pakistan Scotmann Pharma: Velscot (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Pakistan Genix Pharma: Velso (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Pakistan Hilton Pharma: Hilvel (Sofosbuvir/Velpatasvir)400mg/100mg tablets
- Lao Tongmeng Pharmaceutical & Food Co., Ltd.(TLPH): Gienoe (Sofosbuvir/Velpatasvir)400mg/100mg tablets
Sofosbuvir-velpatasvir Other Names: SOF-VEL、Velpatasvir. The fixed-dose combination SOF-VEL (400 mg/100 mg) is FDA-approved for the treatment of chronic hepatitis C genotypes 1 to 6 for the following patient populations:
- Patients without cirrhosis and patients with compensated cirrhosis (Child-Pugh A): sofosbuvir-velpatasvir for 12 weeks
- Patients with decompensated cirrhosis (Child-Pugh B and C): sofosbuvir-velpatasvir plus ribavirin for 12 weeks
Sofosbuvir-velpatasvir is available as a coformulated, once-daily single-pill combination of sofosbuvir 400 mg and velpatasvir 100 mg. The recommended dose is one tablet once daily, taken with or without food.